[What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
作者信息
Weissenbach R
出版信息
Therapeutique. 1972 Dec;48(10):685-8.
PMID:4540974
Abstract
摘要
相似文献
1
[What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
Therapeutique. 1972 Dec;48(10):685-8.
2
Fenbufen--a new nonsteroidal anti-inflammatory agent: comparison with phenylbutazone in rheumatoid arthritis.
Curr Ther Res Clin Exp. 1975 Aug;18(2):295-302.
3
[Clinical trial of Midalgyl in rheumatology].
Lille Med. 1971 Apr;16:S 2:638-9.
4
[Comparison of the effects of phenylbutazone and a combination preparation (Exrheudon) in rheumatic diseases].
MMW Munch Med Wochenschr. 1977 Jan 21;119(3):93-4.
5
[Midalgyl in rheumatology. Study on 50 patients].
Bord Med. 1971 Sep;4(9):2471-2 passim.
6
[Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
Arzneimittelforschung. 1974 Sep;24(9A SUPPL):1425-8.
7
[Nonsteroid anti-inflammatory agents. Value of equimolecular salt of phenylbutazone and piperazine in the treatment of rheumatic diseases].
Therapeutique. 1971 Mar;47(3):231-5.
8
[Clinical experimentation of LD 4644 in O.R.L].
Lille Med. 1973 Nov;18(9):1035-8.
9
[The anti-inflammatory clinical effects of pyrazinobutazone (study of 44 cases with principally rheumatologic indications)].
Rhumatologie. 1972 Mar;24(3):91-100.
10
Anti-inflammatory drugs in rheumatic diseases.
Practitioner. 1974 Oct;213(1276 SPEC NO):519-26.
Zotero 插件